Candida auris fungal infections tripled in the United States between 2019 and 2021 to 1,471, including seven cases resistant to all antifungal treatments, according to Centers for Disease Control and Prevention data reported yesterday in the Annals of Internal Medicine. Twenty-eight states and Washington, D.C., have reported cases since the first U.S. infection in 2013. While not a threat to healthy people, C auris infections “tend to occur in patients who have multiple or prolonged health care encounters or indwelling devices, including those receiving mechanical ventilation,” the authors note.
 
“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said Meghan Lyman, a CDC epidemiologist and lead author of the paper.
 

Related News Articles

Headline
Kindergarten vaccination rates declined during the 2024-25 school year, according to data released July 31 by the Centers for Disease Control and Prevention.…
Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for…
Headline
Five pediatric flu deaths were reported to the Centers for Disease Control and Prevention last week, pushing the total to 266 for the 2024-2025 flu season,…
Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows…
Headline
The Centers for Disease Control and Prevention July 7 announced it is streamlining H5N1 bird flu updates with its routine influenza data given the low public…
Headline
The United States July 7 reached its highest annual measles case tally in 33 years, hitting at least 1,277 confirmed cases across 38 states and the District of…